Multiple sclerosis
- PMID: 30410033
- DOI: 10.1038/s41572-018-0041-4
Multiple sclerosis
Erratum in
-
Author Correction: Multiple sclerosis.Nat Rev Dis Primers. 2018 Nov 22;4(1):49. doi: 10.1038/s41572-018-0050-3. Nat Rev Dis Primers. 2018. PMID: 30467372
Abstract
Multiple sclerosis (MS) is the most common chronic inflammatory, demyelinating and neurodegenerative disease of the central nervous system in young adults. This disorder is a heterogeneous, multifactorial, immune-mediated disease that is influenced by both genetic and environmental factors. In most patients, reversible episodes of neurological dysfunction lasting several days or weeks characterize the initial stages of the disease (that is, clinically isolated syndrome and relapsing-remitting MS). Over time, irreversible clinical and cognitive deficits develop. A minority of patients have a progressive disease course from the onset. The pathological hallmark of MS is the formation of demyelinating lesions in the brain and spinal cord, which can be associated with neuro-axonal damage. Focal lesions are thought to be caused by the infiltration of immune cells, including T cells, B cells and myeloid cells, into the central nervous system parenchyma, with associated injury. MS is associated with a substantial burden on society owing to the high cost of the available treatments and poorer employment prospects and job retention for patients and their caregivers.
Similar articles
-
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.J Autoimmun. 2014 Feb-Mar;48-49:134-42. doi: 10.1016/j.jaut.2014.01.022. Epub 2014 Feb 10. J Autoimmun. 2014. PMID: 24524923 Review.
-
Multiple Sclerosis: Basic and Clinical.Adv Neurobiol. 2017;15:211-252. doi: 10.1007/978-3-319-57193-5_8. Adv Neurobiol. 2017. PMID: 28674983 Review.
-
The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.Brain. 2020 Sep 1;143(9):2637-2652. doi: 10.1093/brain/awaa145. Brain. 2020. PMID: 32710096 Review.
-
Changes observed in multiple sclerosis using magnetic resonance imaging reflect a focal pathology distributed along axonal pathways.J Neurol. 2005 Nov;252 Suppl 5:v25-9. doi: 10.1007/s00415-005-5005-4. J Neurol. 2005. PMID: 16254698 Review.
-
Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.Brain. 2014 Sep;137(Pt 9):2456-68. doi: 10.1093/brain/awu171. Epub 2014 Jun 24. Brain. 2014. PMID: 24966048
Cited by
-
Diffuse white matter pathology in multiple sclerosis during treatment with dimethyl fumarate-An observational study of changes in normal-appearing white matter using proton magnetic resonance spectroscopy.PLoS One. 2024 Oct 21;19(10):e0309547. doi: 10.1371/journal.pone.0309547. eCollection 2024. PLoS One. 2024. PMID: 39432495 Free PMC article.
-
Fluid biomarkers in multiple sclerosis: from current to future applications.Lancet Reg Health Eur. 2024 Aug 22;44:101009. doi: 10.1016/j.lanepe.2024.101009. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39444698 Free PMC article. Review.
-
Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis.Brain Commun. 2023 Oct 31;6(1):fcad300. doi: 10.1093/braincomms/fcad300. eCollection 2024. Brain Commun. 2023. PMID: 38192492 Free PMC article.
-
Monitoring the Redox Status in Multiple Sclerosis.Biomedicines. 2020 Oct 12;8(10):406. doi: 10.3390/biomedicines8100406. Biomedicines. 2020. PMID: 33053739 Free PMC article. Review.
-
Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management.Nutrients. 2024 Sep 5;16(17):2996. doi: 10.3390/nu16172996. Nutrients. 2024. PMID: 39275311 Free PMC article. Review.
References
-
- Lublin, F. D. et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83, 278–286 (2014). This is a proposal for a redefinition of MS clinical courses on the basis of the inclusion of disease activity (considering clinical relapse rate and imaging findings) and disease progression. - PubMed - PMC - DOI
-
- Multiple Sclerosis International Federation. Atlas of MS 2013: mapping multiple sclerosis around the world. MSIF.org https://www.msif.org/wp-content/uploads/2014/09/Atlas-of-MS.pdf (2013).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical